>
>
Indication evaluation and prioritization for development stage pharmaceutical client
Service Areas
Therapeutic Areas
Client Type
Pre-clinical client
Client Problems
- A privately-held, development stage pharmaceutical company wanted to understand the clinical and commercial factors across a breadth of indications in order to prioritize development
- There were initial thoughts on several broad disease areas, but no concrete goal or therapeutic target
What We Did
- Started with a narrow selection of indication in the first round of study, and then expanded into a total of 12 indications (grouped into three broad categories) to assess the full potential breadth of the market
Our Results And Insight
- Indications were evaluated along commercial, technical, and clinical dimensions.
- Within these dimensions, scores were assigned across 14 sub-categories, and summed to represent total opportunity
- Based on these scores and other factors, indications were ranked from highest to lowest opportunity
See other case studies
Service Areas Details
Commercial Strategy (Indication Prioritization)
Therapeutic Areas Details
Gene Therapy & Orphan Disease